loader

World Tenders & Procurement Opportunities

Search
Advanced Search

Conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V (open house model) - 280564-2024

World Biggest Tenders Source

This tender with title Conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V (open house model) - 280564-2024 has been published on Bidding Source portal dated 17 May 2024 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V (open house model) - 280564-2024
Invitation for Bids
Germany
17 May 2024
1 May 2026
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient dolutegravir and rilpivirine (J05AR21) within the framework of a so-called open-house model. - 347568-2024 Germany Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient sulfasalazine (ATC code: M01CX02). - 349711-2024 Germany Pharmaceutical products – 52nd Generics Tender_GW - 352365-2024 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient alitretinoin (D11AH04) within the framework of a so-called open-house model. - 345852-2024 Germany Conclusion of non-exclusive drug discount agreements pursuant to Section 130a Paragraph 8 SGB V by means of a so-called open house model for the active ingredient ranolazine (ATC code WHO: C01EB18) - 347567-2024 Germany Conclusion of non-exclusive drug discount agreements pursuant to Section 130a Paragraph 8 SGB V by means of a so-called open house model for the active ingredient cinacalcet (ATC code WHO: H05BX01) - 347625-2024 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the possibility of conclusion within the framework of the so-called open house procedure. - 348176-2024 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient colistin (J01XB01) within the framework of a so-called open-house model. - 349436-2024 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient desloratadine (R06AX27) within the framework of a so-called open-house model. - 349850-2024 Germany Drug discount agreements pursuant to Section 130a Para. 8 SGB V within the framework of open-house procedures - 350334-2024 Germany
Pharmaceutical products Tenders
Germany Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans